Cargando…

Carrier screening in individuals of Ashkenazi Jewish descent

Detalles Bibliográficos
Autores principales:	Gross, Susan J., Pletcher, Beth A., Monaghan, Kristin G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott, Williams & Wilkins 2008
Materias:	ACMG Practice Guidelines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110977/ https://www.ncbi.nlm.nih.gov/pubmed/18197057 http://dx.doi.org/10.1097/GIM.0b013e31815f247c

Ejemplares similares

Preconception and prenatal testing of biologic fathers for carrier status
por: Pletcher, Beth A., et al.
Publicado: (2006)

Fragile X syndrome: Diagnostic and carrier testing
por: Sherman, Stephanie, et al.
Publicado: (2005)

Indications for genetic referral: a guide for healthcare providers
por: Pletcher, Beth A., et al.
Publicado: (2007)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

First trimester diagnosis and screening for fetal aneuploidy
por: Driscoll, Deborah A., et al.
Publicado: (2008)

Screening for fetal aneuploidy and neural tube defects
por: Driscoll, Deborah A., et al.
Publicado: (2009)

Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasia
por: Clericuzio, Carol L., et al.
Publicado: (2009)

American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation
por: Shaffer, Lisa G.
Publicado: (2005)

Clinical genetics evaluation in identifying the etiology of autism spectrum disorders
por: Schaefer, G. Bradley, et al.
Publicado: (2008)

High mammographic density in women of Ashkenazi Jewish descent
por: Caswell, Jennifer L, et al.
Publicado: (2013)

Pompe disease diagnosis and management guideline
por: Kishnani, Priya S., et al.
Publicado: (2006)

Statement on guidance for genetic counseling in advanced paternal age
por: Toriello, Helga V., et al.
Publicado: (2008)

Genetic evaluation of suspected osteogenesis imperfecta (OI)
por: Byers, Peter H., et al.
Publicado: (2006)

ACMG practice guideline: Genetic evaluation of short stature
por: Seaver, Laurie H., et al.
Publicado: (2009)

Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities
por: Manning, Melanie, et al.
Publicado: (2010)

Erratum
Publicado: (2009)

Beyond the “Jewish panel”: the importance of offering expanded carrier screening to the Ashkenazi Jewish population
por: Dolitsky, Shelley, et al.
Publicado: (2020)

A collaborative genetic carrier screening model for the British Ashkenazi Jewish community
por: Ziff, Monica, et al.
Publicado: (2021)

Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women
por: Hardy, Melanie W., et al.
Publicado: (2022)

Lessons learned from expanded reproductive carrier screening in self‐reported Ashkenazi, Sephardi, and Mizrahi Jewish patients
por: Akler, Gidon, et al.
Publicado: (2019)

Genetic architecture of prostate cancer in the Ashkenazi Jewish population
por: Vijai, J, et al.
Publicado: (2011)

Technical Standards and Guidelines for Fragile X: The First of a Series of Disease-Specific Supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics
por: Maddalena, Anne, et al.
Publicado: (2001)

The time and place of European admixture in Ashkenazi Jewish history
por: Xue, James, et al.
Publicado: (2017)

American College of Medical Genetics Statement on Diagnostic Testing for Uniparental Disomy
por: Shaffer, Lisa G., et al.
Publicado: (2001)

Informed consent for medical photographs
por: Cunniff, Christopher, et al.
Publicado: (2000)

Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry
por: Tennen, Ruth I., et al.
Publicado: (2020)

Genetics Evaluation Guidelines for the Etiologic Diagnosis of Congenital Hearing Loss
Publicado: (2002)

Carrier frequencies of eleven mutations in eight genes associated with primary ciliary dyskinesia in the Ashkenazi Jewish population
por: Fedick, Anastasia M, et al.
Publicado: (2015)

Ashkenazi Jewish and Other White APC I1307K Carriers Are at Higher Risk for Multiple Cancers
por: Forkosh, Esther, et al.
Publicado: (2022)

Implications for health and disease in the genetic signature of the Ashkenazi Jewish population
por: Guha, Saurav, et al.
Publicado: (2012)

Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk
por: Hamada, Tsuyoshi, et al.
Publicado: (2019)

Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population
por: Rivas, Manuel A., et al.
Publicado: (2018)

Hereditary cancer screening: Case reports and review of literature on ten Ashkenazi Jewish founder mutations
por: Cox, Devin M., et al.
Publicado: (2018)

Ashkenazi Jewish Centenarians Do Not Demonstrate Enrichment in Mitochondrial Haplogroup J
por: Shlush, Liran I., et al.
Publicado: (2008)

Genetic Complexity of Crohn’s Disease in Two Large Ashkenazi Jewish Families
por: Levine, Adam P., et al.
Publicado: (2016)

Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry
por: Wang, Zhaoming, et al.
Publicado: (2012)

Correction: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population
por: Rivas, Manuel A., et al.
Publicado: (2019)

How old is this mutation? - a study of three Ashkenazi Jewish founder mutations
por: Greenwood, Celia MT, et al.
Publicado: (2010)

Ashkenazi Jewish Origin Protects Against Formation of Antibodies to Infliximab and Therapy Failure
por: Ungar, Bella, et al.
Publicado: (2015)

Differences in MS clinical and epidemiological characteristics between Ashkenazi and non-Ashkenazi Jewish patients in Israel: a retrospective single center study
por: Karni, Arnon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5sta6fsg8v27kqon1eq3tha3la